Shmuel Ben Zvi
Director/Board Member bij BANK LEUMI LE-ISRAEL B.M.
Vermogen: - $ op 31-03-2024
Profiel
Shmuel Ben Zvi is an Independent Director at Bank Leumi Le-Israel B.M.
since 2015 and at Protalix Biotherapeutics, Inc. since 2022.
He is also the Manager & Owner of Shmuel (Muli) Ben Zvi Ltd.
Dr. Ben Zvi previously served as the Deputy CEO, VP-Finance & Strategy at Teva Pharmaceutical Industries Ltd.
from 2004 to 2014.
He was an Independent Non-Executive Director at Vascular Biogenics Ltd.
from 2018 to 2023.
Additionally, he held the position of Head-Budget Department at Israel Ministry of Defense from 2000 to 2004.
Dr. Ben Zvi has an educational background from Tel-Aviv University, where he obtained undergraduate, graduate, and doctorate degrees.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 29-09-2023 | 0 ( -.--% ) | - $ | 31-03-2024 |
Actieve functies van Shmuel Ben Zvi
| Bedrijven | Functie | Begin |
|---|---|---|
| BANK LEUMI LE-ISRAEL B.M. | Director/Board Member | 29-07-2015 |
| PROTALIX BIOTHERAPEUTICS, INC. | Director/Board Member | 30-06-2022 |
| Shmuel (Muli) Ben Zvi Ltd. | Corporate Officer/Principal | - |
Eerdere bekende functies van Shmuel Ben Zvi
| Bedrijven | Functie | Einde |
|---|---|---|
| NOTABLE LABS, LTD. | Director/Board Member | 16-10-2023 |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-12-2014 |
| Israel Ministry of Defense | Corporate Officer/Principal | 01-01-2004 |
| SOL-GEL TECHNOLOGIES LTD. | Director/Board Member | - |
Opleiding van Shmuel Ben Zvi
| Tel-Aviv University | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 4 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| BANK LEUMI LE-ISRAEL B.M. | Finance |
| SOL-GEL TECHNOLOGIES LTD. | Health Technology |
| PROTALIX BIOTHERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 3 |
|---|---|
| Israel Ministry of Defense | Government |
Vascular Biogenics Ltd.
 Vascular Biogenics Ltd. BiotechnologyHealth Technology Vascular Biogenics Ltd. is a clinical-stage biopharmaceutical company, which engages in the development of next-generation, targeted medicines for difficult-to-treat medical conditions. Its product candidates are built off of its platform technologies: Vascular Targeting System (VTS), a gene-based technology targeting newly formed blood vessels and Monocyte Targeting Technology (MTT), an antibody-based technology able to specifically inhibit monocyte migration for immune-inflammatory applications. The company was founded by Dror Harats and Jacob George on January 27, 2000 and is headquartered in Modi'in, Israel. | Health Technology |
| Shmuel (Muli) Ben Zvi Ltd. |
